Archive | Financial health RSS feed for this section

The Average Price of a New Specialty Drug Exceeds Median U.S. Annual Income; and a Tweet from Pam Anderson

The average price for a specialty drug was $53,384 in 2013; the average household income was $52,250. Thus, even allocating 100% of a family’s annual earnings to pay for a drug wouldn’t stretch far enough to cover it in 2013, nor would it do so today in 2015. This sober health economic artifact comes from the […]

Read full story Comments { 0 }

American health citizens hungry for cost controls

Most Americans support price controls on drug and medical device manufacturers, hospitals, and payments to doctors, along with allowing Medicare to negotiate drug prices. U.S. health citizens, now consumers, have been experiencing sticker-shock when it comes to prices on medical bills upon hospital discharge, leaving the doctor’s office, filling a prescription at a pharmacy or […]

Read full story Comments { 1 }

My Breakfast With Alain – On Health Consumers and the New Retail Health

My National Health Care Consumer Week, I’ll coin this, looking back on flying some 12,000 airmiles over six days, criss-crossing America from the City of Brotherly Love to Sacramento, back to Philly and then to Los Angeles. Finally, today, heading home to Philadelphia and my beloved, most necessary Tempur-Pedic bed, a loving husband and some […]

Read full story Comments { 0 }

In 2016 Prescription Drugs Will Be The Fastest-Growing Component of Healthcare Costs

In 2016, prescription drug trend will rise over 11%. In contrast, medical trend growth for high-deductible health plans is expected to be 8%, hospital services 8.2%, and physician services 5.5%,   according to the 2016 Segal Health Plan Cost Trend Survey released in September 2015. By definition, “trend” is the forecast of per capita health insurance […]

Read full story Comments { 0 }

U.S. Consumers’ View of Pharma Goes Negative in 2015

Americans’ views of the pharmaceutical industry have fallen in the past year, with negative perceptions outweighing positive ones, shown in the line graph from the Gallup Poll. Pharma’s low-lying reputation among consumers sits among others including the legal field, healthcare, oil and gas, and the Federal government which ranked lowest across all 25 sectors Gallup […]

Read full story Comments { 0 }